These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 16427856)
41. Impact of preoperative neurologic events on outcomes after coronary artery bypass grafting. Halkos ME; Puskas JD; Lattouf OM; Kilgo P; Guyton RA; Thourani VH Ann Thorac Surg; 2008 Aug; 86(2):504-10; discussion 510. PubMed ID: 18640324 [TBL] [Abstract][Full Text] [Related]
42. The impact of left ventricular hypertrophy on early and long-term survival after coronary artery bypass grafting. Toumpoulis IK; Chamogeorgakis TP; Angouras DC; Swistel DG; Anagnostopoulos CE; Rokkas CK Int J Cardiol; 2009 Jun; 135(1):36-42. PubMed ID: 18579225 [TBL] [Abstract][Full Text] [Related]
43. Does preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting? Ad N; Barnett SD; Haan CK; O'Brien SM; Milford-Beland S; Speir AM J Thorac Cardiovasc Surg; 2009 Apr; 137(4):901-6. PubMed ID: 19327515 [TBL] [Abstract][Full Text] [Related]
44. Long-term prognostic value of creatine kinase-myocardial band mass after cardiac surgery in low-risk patients with stable angina. Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE Cardiology; 2009; 113(2):122-31. PubMed ID: 19039220 [TBL] [Abstract][Full Text] [Related]
45. Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time. Smith PK; Carrier M; Chen JC; Haverich A; Levy JH; Menasché P; Shernan SK; Van de Werf F; Adams PX; Todaro TG; Verrier E Ann Thorac Surg; 2006 Sep; 82(3):781-8; discussion 788-9. PubMed ID: 16928483 [TBL] [Abstract][Full Text] [Related]
46. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery. Goyal A; Alexander JH; Hafley GE; Graham SH; Mehta RH; Mack MJ; Wolf RK; Cohn LH; Kouchoukos NT; Harrington RA; Gennevois D; Gibson CM; Califf RM; Ferguson TB; Peterson ED; Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447 [TBL] [Abstract][Full Text] [Related]
49. Impact of off-pump techniques on sex differences in early and late outcomes after isolated coronary artery bypass grafts. Fu SP; Zheng Z; Yuan X; Zhang SJ; Gao HW; Li Y; Hu SS Ann Thorac Surg; 2009 Apr; 87(4):1090-6. PubMed ID: 19324133 [TBL] [Abstract][Full Text] [Related]
52. Effect of complications on mortality after coronary artery bypass grafting surgery: evidence from New York State. Glance LG; Osler TM; Mukamel DB; Dick AW J Thorac Cardiovasc Surg; 2007 Jul; 134(1):53-8. PubMed ID: 17599486 [TBL] [Abstract][Full Text] [Related]
53. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention. Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825 [TBL] [Abstract][Full Text] [Related]
54. The effect of previous coronary artery stenting on short- and intermediate-term outcome after surgical revascularization in patients with diabetes mellitus. Tran HA; Barnett SD; Hunt SL; Chon A; Ad N J Thorac Cardiovasc Surg; 2009 Aug; 138(2):316-23. PubMed ID: 19619774 [TBL] [Abstract][Full Text] [Related]
55. Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery. Kubal C; Srinivasan AK; Grayson AD; Fabri BM; Chalmers JA Ann Thorac Surg; 2005 May; 79(5):1570-6. PubMed ID: 15854935 [TBL] [Abstract][Full Text] [Related]